Versigent (NYSE:VGNT) Posts Quarterly Earnings Results, Beats Estimates By $0.34 EPS

Key Points

• Versigent beat earnings expectations: The company reported quarterly EPS of $1.92, exceeding the $1.58 consensus estimate by $0.34. Net sales rose 11% year over year to $2.4 billion, while adjusted EBITDA increased 25% to $272 million.
• 2026 sales guidance was raised to $9.4 billion-$9.6 billion, although adjusted EBITDA and free cash flow forecasts were maintained at $950 million-$1.03 billion and $200 million-$300 million, respectively.
• Growth initiatives and shareholder returns expanded: Versigent launched a $0.13 quarterly dividend and retains $250 million under its share-repurchase authorization, but management warned of second-half pressure from weaker automotive production, softer EMEA demand, and program-launch costs.

Versigent (NYSE:VGNT - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.58 by $0.34, Zacks reports.

Here are the key takeaways from Versigent's conference call:

• Versigent reported strong second-quarter results, with net sales up 11% year over year to $2.4 billion, adjusted EBITDA up 25% to $272 million, and margin expanding 120 basis points to 11.1%. Underlying adjusted sales growth was approximately 5%, outpacing relatively flat-to-down global automotive production.
• The company cited robust commercial momentum, including $2.8 billion in second-quarter bookings and 39 large-scale program launches with more than 99% quality and on-time delivery. Growth was particularly strong in the Americas and Asia-Pacific, supported by customer launches and China-related vehicle exports.
• Versigent raised its 2026 sales guidance to $9.4 billion-$9.6 billion, primarily due to higher copper pass-throughs and favorable foreign exchange, but maintained adjusted EBITDA guidance of $950 million-$1.03 billion because those macro benefits are not expected to materially improve profitability. The company also reaffirmed free cash flow guidance of $200 million-$300 million.
• Management expects second-half pressure from lower global automotive production, customer-specific schedule reductions, softer EMEA demand, and temporary volume and absorption impacts from an unusually high number of program launches. European adjusted sales declined 11% in the quarter, prompting targeted actions to improve regional competitiveness.
• The company initiated a quarterly dividend of $0.13 per share and has $250 million remaining under its share-repurchase authorization, supported by its projected cash generation and approximately $1 billion of cumulative free cash flow from 2026 through 2028. Management also identified commercial vehicles, agriculture, battery energy storage, and robotics as potential longer-term growth opportunities not included meaningfully in its 2028 outlook.

Versigent Stock Performance

NYSE VGNT traded up $3.35 during trading on Tuesday, reaching $45.39. 251,434 shares of the stock traded hands, compared to its average volume of 2,062,580. The firm's 50-day moving average is $43.28. Versigent has a fifty-two week low of $26.34 and a fifty-two week high of $50.88.

Analysts Set New Price Targets

VGNT has been the subject of several recent research reports. Wall Street Zen raised Versigent to a "hold" rating in a report on Saturday, April 18th. Argus set a $50.00 target price on shares of Versigent in a research note on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft upgraded shares of Versigent from a "hold" rating to a "buy" rating and set a $50.00 price target for the company in a research report on Tuesday, July 7th. Royal Bank Of Canada boosted their price target on shares of Versigent from $34.00 to $41.00 and gave the stock a "sector perform" rating in a research note on Monday, July 13th. Finally, UBS Group cut their price objective on shares of Versigent from $58.00 to $55.00 and set a "buy" rating on the stock in a report on Thursday, July 9th. Three research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Versigent currently has an average rating of "Buy" and a consensus price target of $49.67.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.